Impaired Calcium Homeostasis and Calcium Antagonists in Muscle Diseases

  • S. Zierz
Conference paper


The electrical excitation of the muscle plasma membrane following a nerve impulse spreads into the T-tubule system. The electrical signal is then transferred to the sarcoplasmic reticulum, and large amounts of Ca2+ stored in its lumen are released into the cytosol. In the resting state at low cytosolic Ca2+ concentrations (about 10−7 M), tropomyosin sterically blocks the interaction of myosin heads with actin. When the cytosolic Ca2+ level is raised up to 10−5 M following the electrical excitation, free Ca2+ interacts with troponin, resulting in a conformational change of the tropomyosin, allowing the myosin heads to interact with actin. Subsequently, the Ca2+ concentrations of the myofibrillar compartment are rapidly restored to the resting level by uptake of Ca2+ into the sarcoplasmic reticulum through the Ca2+-Mg2+ ATPase located in the sarcoplasmic reticulum [19].


Sarcoplasmic Reticulum Calcium Antagonist Duchenne Muscular Dystrophy Malignant Hyperthermia Myotonic Dystrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bertorini TE, Palmieri GMA, Griffin JW et al. (1988) Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy. Neurology 38:609–613PubMedCrossRefGoogle Scholar
  2. 2.
    Bodensteiner JB, Engel AG (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies. Neurology 28:439–446PubMedCrossRefGoogle Scholar
  3. 3.
    Brody IA (1969) Muscle contracture induced by exercise. N Engl J Med 281:187–192PubMedCrossRefGoogle Scholar
  4. 4.
    Carafoli E (1987) Intracellular calcium homeostasis. Ann Rev Biochem 56:395–433PubMedCrossRefGoogle Scholar
  5. 5.
    Carafoli E, Roman I (1980) Mitochondria and disease. Mol Aspects Med 3:295–429CrossRefGoogle Scholar
  6. 6.
    Cook JD, Henderson-Tilton AC, Daigh JD, Oliver YP (1984) Beneficial response to a Ca++ channel antagonist in myotonic syndromes. Neurology 34(Suppl 1): 193–194Google Scholar
  7. 7.
    Danon MJ, Karpati G, Charuk J, Holland P (1988) Sarcoplasmic reticulum adenosine triphosphatase deficiency with probable autosomal dominant inheritance. Neurology 38:812–814PubMedCrossRefGoogle Scholar
  8. 8.
    Dick DJ, Gardner-Medwin D, Gates PG, Gibson M, Simpson JM, Walls TJ (1986) A trial of flunarizine in the treatment of Duchenne muscular dystrophy. Muscle Nerve 9:349–354PubMedCrossRefGoogle Scholar
  9. 9.
    Emery AEH, Skinner R, Howden LC, Matthews MB (1982) Verapamil in Duchenne muscular dystrophy. Lancet 1:559PubMedCrossRefGoogle Scholar
  10. 10.
    Gallant EM, Foldes FF, Rempel WE, Gronert GA (1985) Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia. Anesth Analg 64:601–606PubMedCrossRefGoogle Scholar
  11. 11.
    Grant R, Sutton DL, Behan PO, Ballantyne JP (1987) Nifedipine in the treatment of myotonia in myotonic dystrophy. J Neurol Neurosurg Psychiatry 50:199–206PubMedCrossRefGoogle Scholar
  12. 12.
    Gronert GA, Mott J, Lee J (1988) Aetiology of malignant hyperthermia. Br J Anaesth 60:253–267PubMedCrossRefGoogle Scholar
  13. 13.
    Iaizzo PA, Klein W, Lehmann-Horn F (1988) Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflügers Arch 411:648–653PubMedCrossRefGoogle Scholar
  14. 14.
    Karpati G, Charuk J, Carpenter S, Jablecki C, Holland P (1986) Myopathy caused by a deficiency of Ca++ ATPase in sarcoplasmic reticulum (Brody’s disease). Ann Neurol 20:38–49PubMedCrossRefGoogle Scholar
  15. 15.
    Klip A, Elder B, Ruiz-Funes HP, Buchwald M, Grinstein S (1985) The free cytoplasmic Ca++ levels in Duchenne muscular dystrophy lymphocytes. Muscle Nerve 8:317–320PubMedCrossRefGoogle Scholar
  16. 16.
    Lane RJM, Turnbull DM, Welch JL, Walton J (1986) A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. Muscle Nerve 9:635–641PubMedCrossRefGoogle Scholar
  17. 17.
    Lopez JR, Alamo L, Caputo C, Wikinski J, Ledezma D (1985) Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia. Muscle Nerve 8:355–358PubMedCrossRefGoogle Scholar
  18. 18.
    Lopez JR, Allen PD, Alamo L, Jones D, Sreter FA (1988) Myoplasmic free Ca++ during a malignant hyperthermia episode in swine. Muscle Nerve 11:82–88PubMedCrossRefGoogle Scholar
  19. 19.
    Martonosi AN (1984) Mechanisms of Ca++ release from sarcoplasmic reticulum of skeletal muscle. Physiol Rev 64:1240–1320PubMedGoogle Scholar
  20. 20.
    Mokri B, Engel AG (1975) Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 25:1111–1120PubMedCrossRefGoogle Scholar
  21. 21.
    Mongini T, Ghigo D, Doriguzzi C, Bussolino F, Pescarmona G, Polio B, Schiffer D, Bosia A (1988) Free cytoplasmic Ca++ at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients. Neurology 38:476–480PubMedCrossRefGoogle Scholar
  22. 22.
    Moxley RT, Brooke MH, Fenichel GM et al. (1987) Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine. Muscle Nerve 10:22–33PubMedCrossRefGoogle Scholar
  23. 23.
    Mussini I, DiMauro S, Angelini C (1970) Early ultrastructural and biochemical changes in muscle in dystrophia myotonica. J Neurol Sci 10:585–604PubMedCrossRefGoogle Scholar
  24. 24.
    Sufit RL, Peters HA (1984) Nifedipine relieves exercise-exacerbated myalgias. Muscle Nerve 7:647–649PubMedCrossRefGoogle Scholar
  25. 25.
    Walton J (1981) Diffuse exercise-induced muscle pain of undetermined cause relieved by verapamil. Lancet 1:993PubMedCrossRefGoogle Scholar
  26. 26.
    Zahlmann F, Perloff JK, Durant NN, Campion DS (1983) Acute respiratory failure following intravenous verapamil in Duchenne muscular dystrophy. Am Heart J 3:104–105Google Scholar
  27. 27.
    Zierz S (1988) Calcium and calcium antagonists in Duchenne muscular dystrophy. In: Bartko D, Turcani P, Stern G (eds) New trends in clinical neuropharmacology. John Libbey, London (Current problems in neurology, vol 7, pp 39–43)Google Scholar
  28. 28.
    Zierz S, Engel AG (1985) Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Eur J Biochem 149:207–214PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • S. Zierz
    • 1
  1. 1.Neurologische Universitätsklinik BonnBonnGermany

Personalised recommendations